Hoth Therapeutics (NASDAQ: HOTH) Stock Skyrockets Following Approval of HT-001 Phase 2a Human Trials
Hoth Therapeutics (NASDAQ: HOTH) stock surged over 80% during intraday trading after securing approval for the first-in-human Phase 2a clinical […]
HOTH shares